Aggregation of amyloid proteins is currently involved in more than 20 serious human diseases that are actually untreated, such as Alzheimer's disease (AD). Despite many efforts made to target the amyloid cascade in AD, finding an aggregation inhibiting compound and especially modulating early oligomerization remains a relevant and challenging strategy.We report herein the first examples of small and nonpeptide mimics of acyclic beta-hairpins, showing an ability to delay the fibrillization of amyloid-b (Ab1- 42) peptide and deeply modify its early oligomerization process. Modifications providing better druggability properties such as increased hydrophilicity and reduced peptidic character were performed. We also demonstrate that an appropriate balance between flexibility and stability of the b-hairpin must be reached to adapt to the different shape of the various aggregated forms of the amyloid peptide. This strategy can be investigated to target other challenging amyloid proteins.

Structure-activity relationships of β-hairpin mimics as modulators of amyloid β-peptide aggregation / N. Tonali, J. Kaffy, J. Soulier, M.L. Gelmi, E. Erba, M. Taverna, C. van Heijenoort, T. Ha-Duong, S. Ongeri. - In: EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY. - ISSN 0223-5234. - 154(2018 Jun 25), pp. 280-293. [10.1016/j.ejmech.2018.05.018]

Structure-activity relationships of β-hairpin mimics as modulators of amyloid β-peptide aggregation

M.L. Gelmi;E. Erba;
2018

Abstract

Aggregation of amyloid proteins is currently involved in more than 20 serious human diseases that are actually untreated, such as Alzheimer's disease (AD). Despite many efforts made to target the amyloid cascade in AD, finding an aggregation inhibiting compound and especially modulating early oligomerization remains a relevant and challenging strategy.We report herein the first examples of small and nonpeptide mimics of acyclic beta-hairpins, showing an ability to delay the fibrillization of amyloid-b (Ab1- 42) peptide and deeply modify its early oligomerization process. Modifications providing better druggability properties such as increased hydrophilicity and reduced peptidic character were performed. We also demonstrate that an appropriate balance between flexibility and stability of the b-hairpin must be reached to adapt to the different shape of the various aggregated forms of the amyloid peptide. This strategy can be investigated to target other challenging amyloid proteins.
amyloid; Alzheimer's disease; peptidomimetics; b-Hairpin; oligomerization; fibrillization
Settore CHIM/06 - Chimica Organica
25-giu-2018
18-mag-2018
Article (author)
File in questo prodotto:
File Dimensione Formato  
1-s2.0-S0223523418304227-main.pdf

accesso riservato

Tipologia: Publisher's version/PDF
Dimensione 1.8 MB
Formato Adobe PDF
1.8 MB Adobe PDF   Visualizza/Apri   Richiedi una copia
Post-Print_EJMC_2018_Gelmi.pdf

accesso aperto

Tipologia: Post-print, accepted manuscript ecc. (versione accettata dall'editore)
Dimensione 1.43 MB
Formato Adobe PDF
1.43 MB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/576099
Citazioni
  • ???jsp.display-item.citation.pmc??? 6
  • Scopus 14
  • ???jsp.display-item.citation.isi??? 12
social impact